What does PHYTOSYSTEM do?

PHYTOSYSTEM is a wholesaler in Kortrijk. Private Limited, started on 29 September 2021, 1 establishment.

What is the address of PHYTOSYSTEM?

The registered office of PHYTOSYSTEM is located at Heuleplaats(Heu) 5, 8501 Kortrijk.

Is PHYTOSYSTEM still active?

Yes. According to the CBE (29 October 2026) PHYTOSYSTEM is active, legal situation “Normale toestand”, started on 29 September 2021.

Is PHYTOSYSTEM registered on Peppol?

Yes, PHYTOSYSTEM is registered on the Peppol network with ID 0208:0774745631.

What is the enterprise number of PHYTOSYSTEM?

The enterprise number of PHYTOSYSTEM is BE0774745631.

When was PHYTOSYSTEM founded?

PHYTOSYSTEM was founded on 29 September 2021.

Who are the directors of PHYTOSYSTEM?

According to the 2025 annual accounts, the directors of PHYTOSYSTEM are: Paul Vanvinckenroye, Demagri NV, Manu Projects BV, Urqus BV, Fyto Service DMT BV, Dirk Froidmont, Elroco BV, Firme Dock-Moulin BV.

Is PHYTOSYSTEM a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 September 2021; 4 annual accounts filed, latest fiscal year 2025; 8 directors known from the annual account.

How much profit did PHYTOSYSTEM make in 2025?

PHYTOSYSTEM posted a profit after taxes of € 230,981 in financial year 2025.

What is the revenue of PHYTOSYSTEM?

As a small company, PHYTOSYSTEM is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 587,230.

How much does an employee at PHYTOSYSTEM earn?

The average wage cost per full-time employee at PHYTOSYSTEM was € 85,800 in 2025: staff costs of € 197,290 for 2.3 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHYTOSYSTEM have?

According to the 2025 annual accounts, PHYTOSYSTEM has 2.3 full-time equivalents (FTE).

PHYTOSYSTEM (Private Limited) - Kortrijk - BE0774745631

Dossier PHYTOSYSTEM, printed on 29 October 2026 from databakkes.be/en/0774745631/phytosystem. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHYTOSYSTEM from Kortrijk, company number BE0774745631, closed financial year 2025 with a result of € 230,981 after tax. For that financial year PHYTOSYSTEM recorded a gross margin of € 587,230 and equity of € 1.3 million. Compared with financial year 2024, the result moved from € 263,337 to € 230,981. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 2, 2026.

What it is worth Growing

€ 1.3 million

▲ 21% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 230,981

▼ 12% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 433,710

▲ € 390,616 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1.1 million.

People and assets in 2025

Full-time equivalents

2.3

▲ 1.2 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 197,290

▲ 144% vs 2024

€ 85,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 64,790

▲ 37% vs 2024

Of which on lease € 28,205.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 438,776

▼ 15% vs 2024

€ 70,495 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 1.2 million

▼ 36% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 36,109

▲ 167% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 617,570 Gross margin 2022: € 617,570 First fiscal year in the series	€ 577,355 Gross margin 2023: € 577,355 ▼ 7% vs 2022 (€ 617,570) Unfavourable step	€ 544,069 Gross margin 2024: € 544,069 ▼ 6% vs 2023 (€ 577,355) Unfavourable step	€ 587,230 Gross margin 2025: € 587,230 ▲ 8% vs 2024 (€ 544,069) Favourable step	▲ 8%
Profit after taxes	€ 297,524 Profit after taxes 2022: € 297,524 First fiscal year in the series	€ 292,489 Profit after taxes 2023: € 292,489 ▼ 2% vs 2022 (€ 297,524) Unfavourable step	€ 263,337 Profit after taxes 2024: € 263,337 ▼ 10% vs 2023 (€ 292,489) Unfavourable step	€ 230,981 Profit after taxes 2025: € 230,981 ▼ 12% vs 2024 (€ 263,337) Unfavourable step	▼ 12%
Equity	€ 547,524 Equity 2022: € 547,524 First fiscal year in the series	€ 840,013 Equity 2023: € 840,013 ▲ 53% vs 2022 (€ 547,524) Favourable step	€ 1,103,351 Equity 2024: € 1,103,351 ▲ 31% vs 2023 (€ 840,013) Favourable step	€ 1,334,332 Equity 2025: € 1,334,332 ▲ 21% vs 2024 (€ 1,103,351) Favourable step	▲ 21%
Total debts	€ 2,088,524 Total debts 2022: € 2,088,524 First fiscal year in the series	€ 1,030,666 Total debts 2023: € 1,030,666 ▼ 51% vs 2022 (€ 2,088,524) Favourable step	€ 2,355,181 Total debts 2024: € 2,355,181 ▲ 129% vs 2023 (€ 1,030,666) Unfavourable step	€ 1,631,759 Total debts 2025: € 1,631,759 ▼ 31% vs 2024 (€ 2,355,181) Favourable step	▼ 31%
Cash	€ 214,666 Cash 2022: € 214,666 First fiscal year in the series	€ 149,715 Cash 2023: € 149,715 ▼ 30% vs 2022 (€ 214,666) Unfavourable step	€ 43,094 Cash 2024: € 43,094 ▼ 71% vs 2023 (€ 149,715) Unfavourable step	€ 433,710 Cash 2025: € 433,710 ▲ € 390,616 vs 2024 (€ 43,094) Favourable step	▲ € 390,616
Retained profit	€ 297,524 Retained profit 2022: € 297,524 First fiscal year in the series	€ 590,013 Retained profit 2023: € 590,013 ▲ 98% vs 2022 (€ 297,524) Favourable step	€ 853,351 Retained profit 2024: € 853,351 ▲ 45% vs 2023 (€ 590,013) Favourable step	€ 1,084,332 Retained profit 2025: € 1,084,332 ▲ 27% vs 2024 (€ 853,351) Favourable step	▲ 27%
Bank debt	€ 1,738,467 Bank debt 2022: € 1,738,467 First fiscal year in the series	€ 410,684 Bank debt 2023: € 410,684 ▼ 76% vs 2022 (€ 1,738,467) Favourable step	€ 515,666 Bank debt 2024: € 515,666 ▲ 26% vs 2023 (€ 410,684) Unfavourable step	€ 438,776 Bank debt 2025: € 438,776 ▼ 15% vs 2024 (€ 515,666) Favourable step	▼ 15%
Balance sheet total	€ 2,636,048 Balance sheet total 2022: € 2,636,048 First fiscal year in the series	€ 1,870,680 Balance sheet total 2023: € 1,870,680 ▼ 29% vs 2022 (€ 2,636,048) Unchanged	€ 3,458,532 Balance sheet total 2024: € 3,458,532 ▲ 85% vs 2023 (€ 1,870,680) Unchanged	€ 2,966,091 Balance sheet total 2025: € 2,966,091 ▼ 14% vs 2024 (€ 3,458,532) Unchanged	▼ 14%
Employees (FTE)	1.6 Employees (FTE) 2022: 1.6 First fiscal year in the series	1 Employees (FTE) 2023: 1 ▼ 0.6 vs 2022 (1.6) Unchanged	1.1 Employees (FTE) 2024: 1.1 ▲ 0.1 vs 2023 (1) Unchanged	2.3 Employees (FTE) 2025: 2.3 ▲ 1.2 vs 2024 (1.1) Unchanged	▲ 1.2

Key figures of PHYTOSYSTEM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHYTOSYSTEM?

What happened at PHYTOSYSTEM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2028 Paul Vanvinckenroye stepped down as director. NBB
2028 Demagri NV stepped down as director. NBB
2028 Manu Projects BV stepped down as director. NBB
2028 Dirk Froidmont stepped down as director. NBB
2028 Elroco BV stepped down as director. NBB
Oct 2, 2026 New annual accounts for financial year 2025: profit of € 230,981 (▼ 12% vs 2024). filed late Source: NBB ↗
2026 Paul Vanvinckenroye became a director. NBB
2026 Demagri NV became a director. NBB

In short

From € 297,524 profit in 2022 to € 230,981 profit in 2025.

Paid € 381,596 in corporate taxes since 2022.

Best year ever: 2022, with € 297,524 profit.

On average € 255,300 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

URQUS 10%

FIRME - DOCK - MOULIN 10%

CAPPELLE 10%

SEYNAVE ET FILS 10%

The stake of URQUS, FIRME - DOCK - MOULIN, CAPPELLE, SEYNAVE ET FILS, DEMAGRI, DEVA - FYTO, Auriga Management, DMT Service comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

PHYTOSYSTEM

Paxus 70%

The shares are held by URQUS (10%), FIRME - DOCK - MOULIN (10%), CAPPELLE (10%), SEYNAVE ET FILS (10%), DEMAGRI (10%) and DEVA - FYTO (10%). It owns 70% of Paxus itself.